Nevertheless, in the present case, upadacitinib induced the rapid resolution of a severe RA flare-up occurring during anti-PD-1 ICI therapy for advanced lung squamous cell carcinoma. The gene discussed is PDCD1; the disease is rheumatoid arthritis.